The biotech's candidate may treat a great number of illnesses that have one thing in common.

For investors looking for businesses that can grow steadily across market cycles, this could be the one stock worth watching.

High-yield savings accounts are still paying up to 5.00% APY following a total of three Fed rate cuts in 2025 and a trio of ...

Nvidia faces growing competition from custom AI accelerators. This cloud provider says its chips business could generate $50 ...

What you thought you knew about inflation might be completely altered under the next head of the Federal Reserve.

In this article, I'll focus on Ethereum, particularly why its role as a settlement layer gives it solid long-term potential.

The $25 billion stock buyback plan is a vote of confidence, but the Adobe stock price has an uphill battle to rebound.

Blackstone committed $400 million to fund development of Teva's promising autoimmune disease drug duvakitug. This deal ...

AMD stock has shot up impressively in April, and its upcoming earnings report could give the stock another shot in the arm.

Green Thumb is about as blue chip as it comes in the U.S. cannabis industry. The company has multiple potential catalysts ...

SpaceX confidentially filed for its initial public offering (IPO) on April 1, putting the wheels in motion for what's ...

Warsh's desire to shrink the Fed's balance sheet and discontinue forward guidance could be trouble for the stock market.